UnitedHealth Group ( NYSE:UNH – Get Rating ) ‘s stock had its 'strong-buy' rating restated by analysts at Raymond James in a note issued to investors on Friday, Benzinga reports. They currently have a $630.00 price objective on the healthcare conglomerate's stock. Raymond James' price target indicates a potential upside of 25.15% from the stock's current price. Other equities research analysts have also recently issued research reports about the stock. Royal Bank of Canada reaffirmed an 'outperform' rating and set a $592.

https://www.dailypolitical.com/2023/04/17/unitedhealth-group-nyseunh-given-strong-buy-rating-at-raymond-james.html

#dailypolitical